Efficacy and Safety of a Biosimilar Liraglutide (Melitide®) Versus the Reference Liraglutide (Victoza®) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial
Titel:
Efficacy and Safety of a Biosimilar Liraglutide (Melitide®) Versus the Reference Liraglutide (Victoza®) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial
Auteur:
Esteghamati, Alireza Zamanzadeh, Mehran Malek, Mojtaba Khaledi, Mohammad Monavari, Arezoo Najafi, Laily Banazadeh, Zahra Malboosbaf, Ramin Aghili, Rokhsareh Mahdikhah, Sedigheh Ganjizadeh-Zavereh, Hasan Kafi, Hamidreza Hosseinpanah, Farhad Khamseh, Mohammad Ebrahim